The Lab for Clinical and Integrative Neuroscience (Lab CLINT) is part of Trinity College Institute for Neuroscience at Trinity College Dublin. Lab CLINT aims to advance fundamental knowledge of human brain function and to use this knowledge to help people with psychiatric and neurological disorders. Our research integrates multimodal brain imaging techniques with novel invasive and non-invasive neuromodulation techniques to determine mechanisms underlying neuroplasticity dysfunction. More specifically, we work to understand the mechanisms of (mal)adaptive plasticity and develop new treatment approaches for different neurological (pain, tinnitus, Parkinson's disease, cognitive impairment) and psychiatric diseases (addiction, OCD, depression).
The Noise Begins is an app created to promote understanding and provide escape and relief from tinnitus through story, neuroscience, sound and music. In collaboration with Lab CLINT created by actor and writer Dominic Gately from his own lived experience of the condition, it's available now at the App Store and is coming soon to Google Play for Android.
The Tinnitus Research Initiative launches its TRI Academy online seminar series. The first seminar will be on September 15, 2021, 12:00 - 13:00 CEST and will be organised every third Wednesday of the month. Each seminar contains of two approximately 20-minute presentations that covers different topics related to tinnitus inclduing definition, risk factors and prevalence, tinnitus mechanisms, treatment options, evidence-based and alternative medicine, e-health and Big Data, and more.
More information: Seminars
The 13th Annual Tinnitus Research Initiative (TRI) Conference will take place at Trinity College Dublin, Ireland from June 7 to 10, 2023. Over the years, the annual TRI conference has attracted scientists, physicians, healthcare professionals and industrialists to influence the tinnitus field. This year we envision a unique and historical extension of this gathering to tinnitus patients and caregivers, inviting them to significantly contribute to shaping the field for the generations to come.
While tinnitus is a common symptom, current-day treatments reduce the impact than specifically address the percept itself. Globally, tinnitus sufferers demand a permanent solution to this problem. Although market research demonstrates a strong commercial opportunity, the amount of scientific research and financial investment is small compared to other chronic health conditions. TRI 2023 aims to bring together world-class scientists, industrialists, clinicians and policymakers, patients and caregivers to address these impending issues thereby seeking to bridge the gap between academia, industry, medicine & society (AIMS).